The muscle and expertise to trailblaze
life-transforming therapies

Dyne was founded with a singular focus: to deliver life-transforming therapies for people living with serious muscle diseases. We are utilizing our proprietary FORCE™ platform to overcome the current limitations of muscle tissue delivery with modern oligonucleotide therapeutic candidates. We have assembled an exceptional team with deep experience in muscle disease, rare disorders, drug development and manufacturing and commercialization of novel therapeutics. We have also established a scientific advisory board comprised of leading experts in the fields of muscle disease drug discovery and development and nucleic acid therapeutics, who share our mission.

Because together, we are stronger.

Joachim, living with DM1
Joachim, living with DM1

Our leadership team

Our leadership team brings deep knowledge of muscle diseases and extensive experience in the discovery and clinical development of treatments for rare genetic diseases and novel therapeutic modalities:

Card image cap

Joshua Brumm

President and Chief Executive Officer

Card image cap

Romesh Subramanian, Ph.D.

Chief Scientific Officer

Card image cap

Susanna High, MBA

Chief Operating Officer

Card image cap

Oxana Beskrovnaya, Ph.D.

Senior Vice President, Head of Research

Card image cap

Jonathan McNeill, M.D.

Vice President, Business Development

Card image cap

Chris Mix, M.D.

Senior Vice President, Clinical Development

Expanded Leadership team
Card image cap

John Davis, Ph.D.

Vice President, Head of Preclinical Development

Card image cap

Debra Feldman

Vice President, Head of Regulatory

Card image cap

Rick Scalzo

Vice President, Accounting and Administration

Card image cap

Gene Kim

Vice President, Finance

Card image cap

Amy Reilly

Vice President, Corporate Communications and Investor Relations

Card image cap

John Najim, MBA

Vice President, Chemistry, Manufacturing and Controls

Card image cap

Molly White

Vice President, Medical Communications and Advocacy

Card image cap

Mo Qatanani, Ph.D.

Vice President, Program and Alliance Management

Card image cap

Daniel Wilson

Vice President, Head of Intellectual Property

Card image cap

Bruce Wentworth, Ph.D.

Senior Scientific Advisor

Board of directors

Jason Rhodes

Chairman

Joshua Brumm

Ed Hurwitz

Dirk Kersten

Lawrence Klein

David Lubner

Catherine Stehman-Breen

Scientific advisory board

Sudhir Agrawal, D.Phil.

Nancy Andrews, M.D., Ph.D.

Louis Kunkel, Ph.D.

Francesco Muntoni, FRCPCH, FMedSci

Jeffrey Statland, M.D.

Charles Thornton, M.D.

Contact Us

For general inquiries, email us at info@dyne-tx.com.

To learn more about partnerships or working together, email us at partnerships@dyne-tx.com.

For investor and media inquiries, email us at ir@dyne-tx.com

Follow us on

830 Winter Street, Waltham, MA 02451

Offices

830 Winter Street, Waltham, MA 02451
Phone: 781.786.8230
Fax: 781.786.8866